Frequency of Peripheral CD8+ T Cells Expressing Chemo-Attractant Receptors CCR1, 4 and 5 Increases in NPC Patients with EBV Clearance upon Radiotherapy
Authors:
- Shweta MahajanSMShweta Mahajan
- Hayri E. BalciogluHBHayri E. Balcioglu
- Astrid OostvogelsAOAstrid Oostvogels
- Willem A. DikWDWillem A. Dik
- K. C. Allen ChanKCK. C. Allen Chan
- Kwok-Wai LoKLKwok-Wai Lo
- Edwin P. HuiEHEdwin P. Hui
- Anna TsangAnna Tsang
- Joanna TongJTJoanna Tong
- Wai Kei Jacky LamWLWai Kei Jacky Lam
- Kenneth WongKenneth Wong
- Anthony T. C. ChanACAnthony T. C. Chan
Open Access
Abstract
Radiotherapy (RT) is the standard-of-care for Epstein–Barr virus (EBV)-associated nasopharyngeal carcinoma (NPC), where the post-RT clearance of plasma EBV DNA is prognostic. Currently, it is not known whether the post-RT clearance of plasma EBV DNA is related to the presence of circulating T-cell subsets. Blood samples from NPC patients were used to assess the frequency of T-cell subsets relating to differentiation, co-signaling and chemotaxis. Patients with undetectable versus detectable plasma EBV DNA levels post-RT were categorized as clearers vs. non-clearers. Clearers had a lower frequency of PD1+CD8+ T cells as well as CXCR3+CD8+ T cells during RT compared to non-clearers. Clearers exclusively showed a temporal increase in chemo-attractant receptors CCR1, 4 and/or 5, expressing CD8+ T cells upon RT. The increase in CCR-expressing CD8+ T cells was accompanied by a drop in naïve CD8+ T cells and an increase in OX40+CD8+ T cells. Upon stratifying these patients based on clinical outcome, the dynamics of CCR-expressing CD8+ T cells were in concordance with the non-recurrence of NPC. In a second cohort, non-recurrence associated with higher quantities of circulating CCL14 and CCL15. Collectively, our findings relate plasma EBV DNA clearance post-RT to T-cell chemotaxis, which requires validation in larger cohorts.Keywords
Funding Information
- Erasmus MC-CUHK
- the Kingboard Charity Foundation
- the Charlie Lee Precision Immuno-oncology Program of the Chinese University of Hong Kong, Hong Kong SAR
This publication has 55 references indexed in Scilit:
- Tumoral Immune Cell Exploitation in Colorectal Cancer Metastases Can Be Targeted Effectively by Anti-CCR5 Therapy in Cancer PatientsCancer Cell, 2016
- Expression of chemokine receptor CXCR4 is closely correlated with clinical outcome in human nasopharyngeal carcinomaTumor Biology, 2015
- Clinical Application of Anti-CCR4 Monoclonal AntibodyOncology, 2015
- Management of Nasopharyngeal Carcinoma: Current Practice and Future PerspectiveJournal of Clinical Oncology, 2015
- CXCR3 ligands in disease and therapyCytokine & Growth Factor Reviews, 2015
- Plasma Epstein-Barr virus DNA as a biomarker for nasopharyngeal carcinomaChinese Journal of Cancer, 2014
- CCR4 and its ligands: from bench to bedsideInternational Immunology, 2014
- Constitutive activation of distinct NF-κB signals in EBV-associated nasopharyngeal carcinomaThe Journal of Pathology, 2013
- The TNFRs OX40, 4-1BB, and CD40 as targets for cancer immunotherapyCurrent Opinion in Immunology, 2013
- Human memory CCR4+CD8+ T cell subset has the ability to produce multiple cytokinesInternational Immunology, 2009